PharmaCyte Biotech, Inc. PMCB

expiry = 2023-06-09...Offer to Purchase by PharmaCyte Biotech, Inc. Up to 7,750,000 Shares of its Common Stock At a Cash Purchase Price of $3.25 per Share CUSIP: 71715X203 THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS WILL EXPIRE AT ONE MINUTE AFTER 11:59 P.M., NEW YORK CITY TIME, ON JUNE 9, 2023, UNLESS THE OFFER IS EXTENDED OR TERMINATED (SUCH DATE AND TIME, AS THEY MAY BE EXTENDED, THE “EXPIRATION DATE”). PharmaCyte Biotech, Inc., a Nevada corporation (the “Company,” “PharmaCyte,” “we,” “us” or “our”), invites our stockholders t...

listed = True...ore than 2% of the outstanding Shares without extending the Offer. See Section 1. THE OFFER IS NOT CONDITIONED ON ANY MINIMUM NUMBER OF SHARES BEING TENDERED. THE OFFER IS, HOWEVER, SUBJECT TO CERTAIN OTHER CONDITIONS. SEE SECTION 7. The Shares are listed and traded on The Nasdaq Stock Market (“Nasdaq”) under the trading symbol “PMCB.” On May 10, 2023, one trading day prior to the commencement of the Offer, the last reported sale price of the Shares was $2.74 per Share. Stockholders are urged to obtain current market quotations for the Shares before deciding whether to tender their Shares. See Section 8. 1 OUR BOARD OF DIRECTORS HAS A...

mechanism = FIXEDEX-1 2 pharmacyte_exa1a.htm OFFER TO PURCHASE EXHIBIT (a)(1)(A) Offer to Purchase by PharmaCyte Biotech, Inc. Up to 7,750,000 Shares of its Common Stock At a Cash Purchase Price of $3.25 per Share CUSIP: 71715X203 THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS WILL EXPIRE AT ONE MINUTE AFTER 11:59 P.M., NEW YORK CITY TIME, ON JUNE 9, 2023, UNLESS THE OFFER IS EXTENDED OR TERMINATED (SUCH DATE AND TIME, AS THEY MAY BE EXTENDED, THE “EXPIRATION DATE”). PharmaCyte Biotech, Inc., a Nevada corporation (the “Company,” “PharmaCyte,” “...

must_tender_all = True...have been properly tendered and not properly withdrawn prior to the Expiration Date, we will purchase Shares on the following basis: · first, we will purchase Odd Lots (as defined in Section 1) of fewer than 100 Shares at the Purchase Price from stockholders who properly tender all of their Shares and who do not properly withdraw them before the Expiration Date. Tenders of less than all of the Shares owned, beneficially or of record, by such Odd Lot Holder (as defined in Section 1) will not qualify for this preference; · second, after purchasing all Odd Lots that were properly tendered and subject to the conditional tender provisi...

price = USD 3.25EX-1 2 pharmacyte_exa1a.htm OFFER TO PURCHASE EXHIBIT (a)(1)(A) Offer to Purchase by PharmaCyte Biotech, Inc. Up to 7,750,000 Shares of its Common Stock At a Cash Purchase Price of $3.25 per Share CUSIP: 71715X203 THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS WILL EXPIRE AT ONE MINUTE AFTER 11:59 P.M., NEW YORK CITY TIME, ON JUNE 9, 2023, UNLESS THE OFFER IS EXTENDED OR TERMINATED (SUCH DATE AND TIME, AS THEY...

priority = True...uy all Shares properly tendered. If the conditions to the Offer have been satisfied or waived and more than 7,750,000 Shares have been properly tendered and not properly withdrawn prior to the Expiration Date, we will purchase Shares on the following basis: · first, we will purchase Odd Lots (as defined in Section 1) of fewer than 100 Shares at the Purchase Price from stockholders who properly tender all of their Shares and who do not properly withdraw them before the Expiration Date. Tenders of less than all of the Shares owned, beneficially or of record, by such Odd Lot Holder (as defined in Section 1) will not qualify for this preference; · second, after purchasing all Od...

threshold = 100...endered. If the conditions to the Offer have been satisfied or waived and more than 7,750,000 Shares have been properly tendered and not properly withdrawn prior to the Expiration Date, we will purchase Shares on the following basis: · first, we will purchase Odd Lots (as defined in Section 1) of fewer than 100 Shares at the Purchase Price from stockholders who properly tender all of their Shares and who do not properly withdraw them before the Expiration Date. Tenders of less than all of the Shares owned, beneficially or of record, by such Odd Lot Holder (as defined in Section 1) will not qualify for this preference; · second, after purchasing all Od...

txn_type = TENDER_OFFEREX-1 2 pharmacyte_exa1a.htm OFFER TO PURCHASE EXHIBIT (a)(1)(A) Offer to Purchase by PharmaCyte Biotech, Inc. Up to 7,750,000 Shares of its Common Stock At a Cash Purchase Price of $3.25 per Share CUSIP: 71715X203 THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS WILL EXPIRE AT ONE MINUTE AFTER 11:59 P.M., NEW YORK CITY TIME, ON JUNE 9, 2023, UNLESS THE OFFER IS EXTENDED OR TERMINAT...